We’re committed to serving the hemp industry with the world’s finest hemp oil and to leading the way for B2B quality and service. Verdant Oasis is strategically developed with long term investments that ensure unparalleled stable production capacity of phytocannabinoid-rich hemp oil consistent in composition and quality under the strictest regulations.
Verdant Oasis leads the global hemp Industry by providing high-quality phytocannabinoid-rich hemp oil alongside product research and development services to hemp business operators and entrepreneurs.
Carl Germano CNS, CDN Vice President/Chief Business Development Officer
NY Board Certified Clinical Nutritionist and Vice President for Verdant Oasis. He holds a master’s degree in clinical nutrition from New York University and has over 37 years of experience in product development for several of the most significant vitamin supplement companies in the trade. With hundreds of dietary supplement products developed, he continues his efforts in product development and research and is responsible for providing the dietary supplement, medical foods, and beverage industries with the next generation of clinically important phytocannabinoid ingredients. A prolific author with several bestselling trade books, including his most recent “Road To Ananda: The Simple Guide To The Endocannabinoid System, Hemp Phytocannabinoids & Your Health.”
Dr. Jerry Schlesser Chief Operating Officer
Physician scientist, he invented InterVir-A-an antiviral drug evaluated in a multi-year trial at Oregon Health Sciences University. Following the publication of the RCT (p<0.00005) in The Lancet, he founded BioPharmaceuticals Corporation, designing, constructing, and operating Oregon’s first FDA-registered prescription drug manufacturing facility.
He also developed Sterisept-TB Envirochoice Wipes, the first hospital-grade antimicrobial TB disinfectant meeting the US EPA’s strict Design for the Environment (DfE) standards.
Dr. Schlesser founded several nutraceutical companies, including a first physician-centered nutraceutical business, purchased by Schwabe North America, under the Integrative Therapeutics label.
Dr. Magdalena Bujalska Director/Scientific Advisory Board
She is a behavioral pharmacologist, serving as Deputy Dean for Science at the Faculty of Pharmacy at Warsaw Medical University for four years, where she led the Pharmacodynamics and Pathophysiology Department. Her scientific interests have focused on the etiology of various types of pain. She is the author of 73 publications, both original and review papers, that include works related to the cannabinoid system. She has conducted pre-clinical studies and clinical trials. Since 2016, she has served as the President of the Polish Pharmacological Society. Her research team is experienced in the pre-clinical evaluation of the biological effects of cannabinoids as a putative analgesic, antiepileptic, antidepressant, and neuroprotective agents.
Dr. Guy Weerasekera Advisory Board Member
With a proven record of developing highly regarded scientific teams and optimizing staff to increase productivity and capability to meet project milestones. A highly influential leader who streamlines processes across the organization to successfully drive projects and teams forward with complex analytical development activities. Creates a high performance operating culture emphasizing customers, compliance, teamwork, personal accountability, and a strong commitment to achieving business goals. He is an expert in developing, validating, and transferring analytical methods to support commercial product launches. His portfolio includes strategic work at Inovatical Laboratories, Centers for Disease Control and Prevention, Mead, Johnson Nutrition, Johnson & Johnson, Avon, and Nektar Therapeutics.
Chris Kilham Botanical Medicine Ambassador/ Advisory Board Member
Chris Kilham is a medicine hunter, author and educator. The founder of Medicine Hunter Inc., Chris has conducted medicinal plant research in over 45 countries. Chris works with companies to develop and popularize traditional plant-based food and medicinal products into market successes. These include ashwagandha, kava, maca, rhodiola, schisandra, tamanu oil, cat’s claw, dragon’s blood, and hundreds of other plants. Chris also works to bridge worlds, regularly sharing information about other cultures through presentations and media. CNN calls Chris “The Indiana Jones of natural medicine.”
For more than 50 years Chris has explored cannabis in its psychoactive and non-psychoactive forms, including at its source following the last ice age in the Siberian Altay, along the Silk Road, in the Himalayas and throughout Southeast Asia and parts of Africa. Chris delves deeply into the history, lore, composition, biological activities, uses and benefits of plants, and describes cannabis as among the most useful of all plants on earth.
Chris has appeared on over 1500 radio programs and more than 500 TV programs worldwide, with features in The New York Times, ABC News Nightline, Newsweek, CNN, The Dr. Oz Show, NBC Nightly News, Good Morning America, ABC 20/20, Psychology Today, Outside Magazine, FOX News Health, LA Yoga, LA Weekly, New York Magazine, Boston Magazine, UTNE Reader, CNBC Power Lunch, Playboy, VICE, Prevention Magazine, Business Insider, Oprah & Friends, PBS Healing Quest, Woman’s World, and many others. He has additionally appeared on PBS, CNBC Power Lunch, CNN, MSNBC, BBC, NPR, CCTV, France 2, Chelsea Handler’s “Chelsea Does”, and The Preachers. As a TV correspondent and guest he speaks about medicine hunting, traditional botanical medicines, nutraceuticals, psychoactive plants, environmental and cultural preservation and other related topics for a broad and diverse variety of audiences.